Tobacco Use Disorder
📧 Sign up to get email alerts when something new happens for Tobacco Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Short Term Effects of Electronic Cigarettes in Tobacco Dependent Adults [NA]
This clinical trial update reports the completion of a study evaluating the short-term effects of electronic cigarettes in adults dependent …
-
FDA approval · 2017-06-30FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Bupropion hydrochloride sustained-release from ScieGen Pharmaceuticals, Inc. (ANDA 206122). …
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Neurophysiological and Immunological Effects of the Transition From Combustible to Electronic Cigarettes [NA]
A completed clinical trial examining neurophysiological and immunological effects as smokers transition from combustible cigarettes to elect…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement [NA]
This clinical trial evaluated the abuse liability of three electronic tobacco vapor products during an 11-day in-clinic confinement; the stu…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Lorcaserin for Preventing Weight Gain Among Smokers [Phase 1, Phase 2]
Clinical trial update for lorcaserin aimed at preventing weight gain in smokers, spanning Phase 1 and Phase 2, with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients [EARLY_Phase 1]
A Phase 1 feasibility study evaluating a quitline-based smoking cessation intervention in cancer patients completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Behavioral Therapy for Reduction in Smoking Craving [NA]
The clinical trial evaluating behavioral therapy to reduce smoking cravings has completed; no efficacy results are provided in the excerpt.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: An Alternative Dosing Schedule of Varenicline for Smoking Cessation [Phase 2]
A Phase 2 trial evaluated an alternative dosing schedule of varenicline for smoking cessation. The study results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Bupropion in Helping Adults Stop Smoking [Phase 2]
A Phase 2 clinical trial update for bupropion examining smoking-cessation outcomes in adults; the study is completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence [Phase 3]
A Phase 3 trial evaluated the effectiveness of bupropion for smoking cessation in individuals recovering from alcohol dependence. The study …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment [Phase 2]
Phase 2 trial evaluating naltrexone for individuals with hazardous drinking in a smoking-cessation program; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents [Phase 1]
Phase 1 trial assessing the safety of combining modafinil with nicotine replacement therapy in adolescents with tobacco use disorder has com…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Smoking Cessation Program in the Preadmission Clinic [NA]
A completed clinical trial evaluating a smoking cessation program in the preadmission clinic.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers [NA]
This clinical trial update notes that a culturally targeted and individually tailored smoking cessation study for LGBT smokers has completed…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Effectiveness of Patient-centered Community Health Worker Support to Help Patients Control Chronic Disease [NA]
A clinical trial evaluated the effectiveness of patient-centered community health worker support to help patients manage chronic diseases, i…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: A Comparison of the Effectiveness of Two Approaches in Achieving Smoking Abstinence [NA]
A completed clinical study comparing two approaches for achieving smoking abstinence.
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) [Phase 4]
This report notes the completion of a Phase 4 trial evaluating nicotine patch plus naltrexone for individuals with alcoholism and tobacco de…
-
CLINICAL_TRIALS research · 2017-04-20Clinical Trial Update: Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking [NA]
An update on a Boston Children's Hospital clinical trial evaluating a computer-adaptive Screening and Brief Motivational Enhancement Therapy…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Effectiveness of Bupropion for Treating Nicotine Dependence in Young People [Phase 2]
Phase 2 clinical trial results evaluate the effectiveness of bupropion for nicotine dependence in young people; the study is completed with …
-
FDA label_change · 2017-04-14FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application to add a coated mint flavor to Rugby Nicotine Polacrilex Gum, a nicotine replacement therapy for aid…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Screening to Augment Referral to Treatment- Project START [NA]
Clinical Trial Update: Project START by Yale University reports completion and posted results of a study evaluating screening to augment ref…
-
FDA approval · 2017-04-12FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, confirming its continued availability as an over…
-
FDA approval · 2017-04-12FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
The FDA approved a supplemental application for nicotine polacrilex (NICOTINE) gum from P & L Development, LLC.
-
FDA approval · 2017-04-11FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
FDA approved a supplemental application for NICOTINE POLACRILEX, a nicotine replacement therapy, from P & L Development, LLC.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: OCAST Cessation Study [NA]
The OCAST Cessation Study (NCT01921439), sponsored by the University of Oklahoma, has completed the trial. It studied tobacco smoking behavi…